ReVision Implant
Develops a bionic vision implant designed to feed visual signals directly into the brain for sight restoration applications.
Overview
ReVision Implant is building a bionic eye, described as a vision device that feeds directly into the brain. The company targets medical applications for restoring or augmenting vision, with its core differentiation centered on a direct brain-interface approach rather than a conventional external vision aid. The company has raised $4M across one undisclosed round, announced on 2026-05-26 and described as a €4M financing. The funding positions ReVision Implant as an early-stage deep tech medical device company working at the intersection of neurotechnology and visual prosthetics.
Funding History
The bionic eye: ReVision Implant lands €4M for a vision device that feeds directly into your brain
Frequently Asked Questions
- How much has ReVision Implant raised in total?
- ReVision Implant has raised a total of $4M across 1 funding round.
- Who are ReVision Implant's investors?
- ReVision Implant's investors include Undisclosed.
- What does ReVision Implant do?
- ReVision Implant is building a bionic eye, described as a vision device that feeds directly into the brain. The company targets medical applications for restoring or augmenting vision, with its core differentiation centered on a direct brain-interface approach rather than a conventional external vision aid. The company has raised $4M across one undisclosed round, announced on 2026-05-26 and described as a €4M financing. The funding positions ReVision Implant as an early-stage deep tech medical device company working at the intersection of neurotechnology and visual prosthetics.
- Where is ReVision Implant headquartered?
- ReVision Implant is headquartered in San Francisco, CA.
Investors
Related Insights
The definitive guide to AI startup funding in 2026 — from pre-seed through IPO, covering valuation mechanics, timelines, investor expectations, and how AI companies differ from traditional tech startups.
An in-depth look at how AI-focused venture capital operates — from fund structure and deal sourcing to due diligence, portfolio management, and exit strategies in the AI era.
A data-driven analysis of AI funding across all 17 sectors — from Foundation Models to AI Healthcare — with sector totals, deal counts, top companies, and investment trends for 2026.